Atherogenic properties of human monocytes induced by the carboxyl terminal proteolytic fragment of alpha-1-antitrypsin

Schmitz, 1998, T-lymphocytes and monocytes in atherogenesis, Herz, 23, 168, 10.1007/BF03044602 McEvoy, 1997, Anti-CD43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis, Blood, 90, 3587, 10.1182/blood.V90.9.3587 Murakami, 1996, Modification of macrophage function and effects on atherosclerosis, Curr. Opin. Lipidol., 7, 320, 10.1097/00041433-199610000-00010 Smith, 1977, Molecular interactions in human atherosclerotic plaques, Am. J. Pathol., 86, 665 Hollander, 1979, Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, α1-antitrypsin and α2-macroglobulin, Atherosclerosis, 34, 391, 10.1016/0021-9150(79)90064-9 Travis, 1983, Human plasma proteinase inhibitors, Annu. Rev. Biochem., 52, 655, 10.1146/annurev.bi.52.070183.003255 Perlmutter, 1985, Expression of α-1-proteinase inhibitor gene in human monocytes and macrophages, Proc. Natl. Acad. Sci., 82, 795, 10.1073/pnas.82.3.795 Issacson, 1981, Alpha-1-antitrypsin in human macrophages, J. Clin. Pathol., 34, 982, 10.1136/jcp.34.9.982 Knoell, 1998, Alpha1-antitrypsin and protease complexation is induced by lipopolysacchride, interleukin-1β in monocytes, Am. J. Respir. Crit. Care Med., 157, 246, 10.1164/ajrccm.157.1.9702033 Perlmuter, 1988, Distinct and additive of elastase and endotoxin on expression of α1 proteinase inhibitor in mononuclear phagocytes, J. Biol. Chem., 263, 16499, 10.1016/S0021-9258(18)37620-8 Perlmutter, 1989, Interferon β2/interleukin 6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells, J. Clin. Invest., 84, 138, 10.1172/JCI114133 Carrell, 1996, The biostructural pathology of the serpins: critical function of sheet opening mechanism, Biol. Chem. Hoppe-Seyler, 377, 1 Carrell, 1997, Conformational disease, Lancet, 350, 134, 10.1016/S0140-6736(97)02073-4 Bruch, 1988, Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and large increase in conformational stability upon cleavage at their reactive sites, J. Biol. Chem., 263, 166626, 10.1016/S0021-9258(18)37436-2 Engh, 1993, Serpin structures, Behring Inst. Mit., 93, 41 Joslin, 1991, The SEC receptor recognizes a pentapeptide neodomain of α1-antitrypsin-protease complexes, J. Biol. Chem., 266, 11281, 10.1016/S0021-9258(18)99160-X Paakko, 1996, Activated neutrophils secrete stored α1-antitrypsin, Am. J. Respir. Crit. Med., 154, 1829, 10.1164/ajrccm.154.6.8970377 Michaelis, 1990, Human neutrophil collagenase cleaves α-1-antitrypsin, Biochem. J., 270, 809, 10.1042/bj2700809 Winyard, 1991, Proteolytic inactivation of human α-1-antitrypsin by human stromelysin, FEBS Lett., 279, 91, 10.1016/0014-5793(91)80258-5 Potempa, 1979, The inactivation of human plasma α-1-proteinase inhibitor by proteinases from Staphylococcus aureus, J. Biol. Chem., 254, 5317 Virca, 1982, Inactivation of human plasma α-1-proteinase inhibitor by a metalloproteinase from Serratia marcescens, Biochim. Biophys. Acta, 704, 267, 10.1016/0167-4838(82)90155-8 Morihara, 1984, Purification of human plasma α-1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase, J. Biochem. Tokyo, 95, 795, 10.1093/oxfordjournals.jbchem.a134671 Johansson, 1992, Identification of hydrophobic fragments of α-antitrypsin and C1 protease inhibitor in human bile, plasma and spleen, FEBS Lett., 299, 146, 10.1016/0014-5793(92)80234-8 Niemann, 1992, Isolation and serine proteinase activity of the 44-residue C-terminal fragment of α-1-antitrypsin from human placenta, Matrix, 12, 233, 10.1016/S0934-8832(11)80066-1 Ray, 1977, Alpha-1-antitrypsin immunoreactivity in islet cells of adult human pancreas, Cell Tissue Res., 185, 63, 10.1007/BF00226668 Geboes, 1982, Morphological identification of α-1-antitrypsin in the human small intestine, Histopathology, 6, 55, 10.1111/j.1365-2559.1982.tb02701.x Niemann, 1997, Binding of SPAAT, the 44-residue C-terminal peptide of α-1-antitrypsin, to proteins of the extracellular matrix, J. Cell. Biochem., 66, 346, 10.1002/(SICI)1097-4644(19970901)66:3<346::AID-JCB7>3.0.CO;2-P Barbey-Morel, 1991, Effect of pseudomonas elastase on human mononuclear phagocyte α-1-antitrypsin expression, Pediatr. Res., 29, 133, 10.1203/00006450-199102000-00005 Janciauskiene, 1997, Low density lipoprotein catabolism is enhanced by the cleaved form of α-1-antitrypsin, Scand. J. Clin. Lab. Invest., 57, 325, 10.3109/00365519709099406 Mirzabekov, 1996, Pore formation by the cytotoxic istel amyloid peptide amylin, J. Biol. Chem., 271, 1988, 10.1074/jbc.271.4.1988 Behl, 1994, Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77, 817, 10.1016/0092-8674(94)90131-7 Lorenzo, 1996, Amyloid fibril toxicity in Alzheimer’s disease and diabetes, Ann. New York Acad. Sci., 777, 89, 10.1111/j.1749-6632.1996.tb34406.x Janciauskiene, 1995, In vitro fibril formation from α-1-antitrypsin-derived C-terminal peptides, Biol. Chem. Hoppe-Seyler, 376, 415, 10.1515/bchm3.1995.376.7.415 Janciauskiene, 1998, The C-terminal peptide of α-1-antitrypsin increases low density lipoprotein binding in HepG2 cells, Eur. J. Biochem., 254, 460, 10.1046/j.1432-1327.1998.2540460.x Janciauskiene, 1999, Effects of fibrillar C-terminal fragment of cleaved α-1-antitrypsin on cholesterol homeostasis in HepG2 cells, Hepatology, 29, 434, 10.1002/hep.510290217 Mc Farlane, 1958, Efficient trace-labelling of proteins with iodine [Abstract], Nature, 182, 53, 10.1038/182053a0 Lowry, 1951, Protein measurements with folin phenol reagents, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Böyum, 1976, Isolation of lymphocytes, granulocytes and macrophages, Scand. J. Immunol. Suppl., 5, 9, 10.1111/j.1365-3083.1976.tb03851.x Davis, 1986, Preparation and analysis of RNA from eukaryotic cells, 129 Choczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156 Ausubel, 1995, 10:80 Lin, 1991, Isolation of cell membranes for epidermal growth factor receptor studies, Methods Enzymol., 198, 251, 10.1016/0076-6879(91)98026-3 Gavey, 1981, The participation of sterol carrier protein2 in the conversion of cholesterol to cholesterol ester by rat liver microsomes, J. Biol. Chem., 256, 2993, 10.1016/S0021-9258(19)69713-9 Norusis, 1993 Ikeda, 1998, Monocyte-endothelial cell interaction in atherogenesis and thrombosis, Clin. Cardiol., 21, 11, 10.1002/clc.4960210103 Libby, 1996, Macrophages and atherosclerotic plaque stability, Curr. Opin. Lipidol., 7, 330, 10.1097/00041433-199610000-00012 Hiltunen, 1998, Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development, Circulation, 97, 1079, 10.1161/01.CIR.97.11.1079 Weiss, 1977, Evidence for hydroxyl radical generation by human monocytes, J. Clin. Invest., 60, 370, 10.1172/JCI108785 Watanabe, 1996, Inflammatory and immunological nature of atherosclerosis, Int. J. Cardiol., 54, S51, 10.1016/S0167-5273(96)88773-0 Abbink, 1991, Production of monoclonal antibodies against inactivated α-1-antitrypsin. Cross-reactivity with complexed α-1-antitrypsin and application in an assay to determine inactivated and complexed α-1-antitrypsin in biological fluids, J. Immunol. Methods, 143, 197, 10.1016/0022-1759(91)90045-H Desrochers, 1992, Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases, J. Biol. Chem., 267, 5005, 10.1016/S0021-9258(18)42931-6 Mast, 1991, Kinetics and physiologic relevance of the inactivation of α1-proteinase inhibitor, α1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin), J. Biol. Chem., 266, 15810, 10.1016/S0021-9258(18)98480-2 Stockley, 1990, Effect of α-1-proteinase inhibitor on neutrophil chemotaxis, Am. J. Respir. Cell. Mol. Biol., 2, 163, 10.1165/ajrcmb/2.2.163 Matsuure, 1999, Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia—a possible pathogenesis of necrobiotic xanthogranuloma, Atherosclerosis, 142, 355, 10.1016/S0021-9150(98)00260-3 Badman, 1998, Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation, Cell Tissue Res., 291, 285, 10.1007/s004410050998 Richter, 1995, TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptors, J. Immunol., 154, 4142, 10.4049/jimmunol.154.8.4142 Steinberg, 1993, Modified forms of low-density lipoprotein and atherosclerosis, J. Int. Med., 233, 227, 10.1111/j.1365-2796.1993.tb00980.x Calvo, 1998, Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL, J. Lipid Res., 39, 777, 10.1016/S0022-2275(20)32566-9 Nakagawa, 1998, Oxidized LDL increases and interferon-γ decreases expression of CD36 in human monocyte-derived macrophages, Arterioscler. Thromb. Vasc. Biol., 18, 1350, 10.1161/01.ATV.18.8.1350 Xing, 1998, LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions, J. Lipid Res., 39, 2201, 10.1016/S0022-2275(20)32475-5